Brief: Nuvation Bio Q1 EPS USD 0.01
04/05/2026 21:10
May 04 (Reuters) - Nuvation Bio Q1 income from pperations USD 3.881 million. Q1 pretax profit USD 5.397 million Q1 net income USD 5.397 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth